Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
m&a
national blog main
national top stories
2019
activism
acute hepatic porphyria
alnylam pharmaceuticals
applied genetics
archive
bernie sanders
bioethics
biopharma
biotechnology
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
buyout
celgene
charges
congress
crisis
deals
detroit blog main
detroit top stories
drug prices
duchenne
easl
emerging technologies
europe blog main
europe top stories
fatty liver disease
fda
gene delivery
givosiran
house of representatives
What
approval
4
×
gene
4
×
therapy
treat
disease
drug
fda
administration
advanced
advisory
alnylam’s
approves
betting
bff
billion
bio
biopharma
blood
body's
called
cancer
cells
children
committee
conference
controversial
create
crispr
custom
deal
deals
designed
devoted
dna
duchenne
easl
editing
ethical
food
form
Language
unset
Current search:
approval
×
gene
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@slashgear.com
4 years ago
FDA approves $2.1m gene therapy for infants with rare genetic disease
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@theverge.com
7 years ago
Gene-editing tool CRISPR may soon be used to treat humans for the first time
